← FDA DRUG APPROVALS

FDA ANDA · ANDA204139

MEROPENEM

Sponsor: ACS DOBFAR SPA

APPLICATION
ANDA204139
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-09
LATEST ACTION
2025-10-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MEROPENEMPrescription
MEROPENEM 1GM/VIAL · INJECTABLE · INJECTION
MEROPENEMPrescription
MEROPENEM 500MG/VIAL · INJECTABLE · INJECTION

Approval history

2025-10-01Labeling · Supplement 4 · standardAP
2025-10-01Labeling · Supplement 3 · standardAP
2019-09-06Labeling · Supplement 1 · standardAP
2016-06-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →